CellCarta (formerly known as HistoGeneX) is a service provider of biomarker technologies for translational and clinical research and is a CAP, CLIA, and BELAC-accredited laboratory. It provides assay development and testing services to support translational medicine, clinical trials, and in vitro diagnostic applications. The company specializes in the biomarker immune-oncology field.